SMS Pharmaceuticals
Sms Pharmaceuticals Performance
Day Range
- Low 117.20
- High 119.85
52 Week Range
- Low 54.55
- High 140.00
- Open Price119.05
- Previous Close119.00
- Volume66901
Start SIP in SMS Pharmaceuticals
Start SIPSms Pharmaceuticals Investment Rating
-
Master Rating:
-
Sms Pharmaceuticals has an operating revenue of Rs. 600.21 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of 1% needs improvement, ROE of -1% is poor and needs improvement. The company has a reasonable debt to equity of 26%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 20% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 15% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 69 which is a FAIR score but needs to improve its earnings, a RS Rating of 62 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 69 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock definitely has some strength, you may want to examine it in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 167 | 135 | 149 | 149 | 159 | 64 | 61 |
Operating Expenses Qtr Cr | 139 | 109 | 126 | 131 | 146 | 65 | 65 |
Operating Profit Qtr Cr | 28 | 27 | 23 | 18 | 14 | 0 | -4 |
Depreciation Qtr Cr | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
Interest Qtr Cr | 6 | 6 | 6 | 6 | 5 | 5 | 4 |
Tax Qtr Cr | 3 | 4 | 3 | 1 | 0 | -3 | -25 |
Net Profit Qtr Cr | 12 | 9 | 8 | 5 | 1 | -10 | 9 |
Sms Pharmaceuticals Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 4
- Bearish Moving Average
- ___
- 12
- 20 Day
- ₹119.44
- 50 Day
- ₹119.65
- 100 Day
- ₹115.56
- 200 Day
- ₹107.09
- 20 Day
- ₹119.46
- 50 Day
- ₹120.47
- 100 Day
- ₹119.90
- 200 Day
- ₹99.25
Sms Pharmaceuticals Resistance and Support
Resistance | |
---|---|
First Resistance | 119.77 |
Second Resistance | 121.13 |
Third Resistance | 122.42 |
RSI | 46.84 |
MFI | 55.28 |
MACD Single Line | -0.36 |
MACD | -0.21 |
Support | |
---|---|
First Resistance | 117.12 |
Second Resistance | 115.83 |
Third Resistance | 114.47 |
Sms Pharmaceuticals Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 78,908 | 4,680,823 | 59.32 |
Week | 195,937 | 11,123,358 | 56.77 |
1 Month | 148,390 | 7,630,194 | 51.42 |
6 Month | 172,895 | 8,113,956 | 46.93 |
Sms Pharmaceuticals Result Highlights
SMS Pharmaceuticals Synopsis
NSE-Medical-Generic Drugs
Sms Pharmaceuticals is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 522.05 Cr. and Equity Capital is Rs. 8.47 Cr. for the Year ended 31/03/2023. SMS Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 14/12/1987 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24239TG1987PLC008066 and registration number is 008066.Market Cap | 1,002 |
Sales | 600 |
Shares in Float | 3.05 |
No of funds | 4 |
Yield | 0.25 |
Book Value | 2.03 |
U/D Vol ratio | 2 |
LTDebt / Equity | 24 |
Alpha | 0.12 |
Beta | 0.78 |
SMS Pharmaceuticals
Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
---|---|---|---|---|
Promoters | 64.32% | 64.32% | 64.29% | 64.17% |
Mutual Funds | ||||
Foreign Portfolio Investors | 0.6% | 0.67% | 0.59% | 0.59% |
Individual Investors | 29.07% | 29.04% | 29.01% | 28.82% |
Others | 6.01% | 5.97% | 6.11% | 6.42% |
SMS Pharmaceuticals Management
Name | Designation |
---|---|
Mr. Ramesh Babu Potluri | Chairman & Managing Director |
Mr. Vamsi Krishna Potluri | Executive Director |
Mr. Sarath Kumar Pakalapati | Independent Director |
Mr. Sharvan Kudaravalli | Independent Director |
Mr. Sarvepalli Srinivas | Independent Director |
Dr.(Mrs.) Neelaveni Thummala | Independent Director |
Sms Pharmaceuticals Forecast
Price Estimates
Sms Pharmaceuticals Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-11-08 | Quarterly Results | |
2023-08-08 | Quarterly Results | |
2023-05-24 | Audited Results & Final Dividend | |
2023-02-09 | Quarterly Results | |
2022-11-12 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2023-09-22 | FINAL | Rs.0.30 per share(30%)Final Dividend |
2022-09-23 | FINAL | Rs.0.30 per share(30%)Final Dividend |
SMS Pharmaceuticals FAQs
What is Share Price of SMS Pharmaceuticals ?
SMS Pharmaceuticals share price is ₹118 As on 01 December, 2023 | 01:55
What is the Market Cap of SMS Pharmaceuticals ?
The Market Cap of SMS Pharmaceuticals is ₹1002.3 Cr As on 01 December, 2023 | 01:55
What is the P/E ratio of SMS Pharmaceuticals ?
The P/E ratio of SMS Pharmaceuticals is 32.3 As on 01 December, 2023 | 01:55
What is the PB ratio of SMS Pharmaceuticals ?
The PB ratio of SMS Pharmaceuticals is 2.2 As on 01 December, 2023 | 01:55